KOCAA
Knights of Columbus Asset Advisors’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-32,184
| Closed | -$120K | – | 380 |
|
|
2023
Q4 | $120K | Buy |
32,184
+16,092
| +100% | +$60.2K | 0.01% | 339 |
|
|
2023
Q3 | $34.1K | Hold |
16,092
| – | – | ﹤0.01% | 363 |
|
|
2023
Q2 | $76.6K | Sell |
16,092
-12,783
| -44% | -$60.8K | 0.01% | 351 |
|
|
2023
Q1 | $165K | Hold |
28,875
| – | – | 0.02% | 312 |
|
|
2022
Q4 | $291K | Sell |
28,875
-303
| -1% | -$3.06K | 0.03% | 278 |
|
|
2022
Q3 | $654K | Buy |
29,178
+3,533
| +14% | +$79.2K | 0.07% | 232 |
|
|
2022
Q2 | $635K | Buy |
25,645
+100
| +0.4% | +$2.48K | 0.06% | 239 |
|
|
2022
Q1 | $990K | Buy |
25,545
+288
| +1% | +$11.2K | 0.08% | 230 |
|
|
2021
Q4 | $1.48M | Buy |
25,257
+499
| +2% | +$29.2K | 0.12% | 218 |
|
|
2021
Q3 | $1.47M | Buy |
24,758
+20
| +0.1% | +$1.19K | 0.13% | 212 |
|
|
2021
Q2 | $2.15M | Buy |
24,738
+2,860
| +13% | +$248K | 0.2% | 174 |
|
|
2021
Q1 | $1.8M | Sell |
21,878
-288
| -1% | -$23.7K | 0.18% | 195 |
|
|
2020
Q4 | $2.02M | Sell |
22,166
-13,987
| -39% | -$1.27M | 0.21% | 168 |
|
|
2020
Q3 | $1.45M | Sell |
36,153
-5,254
| -13% | -$210K | 0.18% | 190 |
|
|
2020
Q2 | $1.42M | Buy |
41,407
+1,808
| +5% | +$62K | 0.17% | 184 |
|
|
2020
Q1 | $879K | Sell |
39,599
-25,687
| -39% | -$570K | 0.11% | 262 |
|
|
2019
Q4 | $1.28M | Buy |
+65,286
| New | +$1.28M | 0.11% | 296 |
|